International Prognostic Index (DLBCL)
Prognosis in aggressive non-Hodgkin lymphoma.
Inputs
Age above 60
LDH above normal
ECOG 2 or higher
Ann Arbor stage III or IV
More than 1 extranodal site
Worked calculation
Your values are highlighted.
- Points
When to use
- Newly diagnosed diffuse large B-cell lymphoma.
Pearls and pitfalls
- Survival figures are from the pre-rituximab era; R-IPI groups are 0, 1–2, and 3–5.
Why use
Standard lymphoma risk grouping.
| Criterion | Points |
|---|---|
| Age above 60 | +1 |
| LDH above normal | +1 |
| ECOG 2 or higher | +1 |
| Ann Arbor stage III or IV | +1 |
| More than 1 extranodal site | +1 |